C1426592||PCSK9
C0678941||genetic variants
C0011860||type 2 diabetes
C2718019||mendelian randomisation study
C0360714||Statin
C0087111||treatment
C0678941||variants in the gene
C0020374||HMG-CoA reductase
C0023824||LDL cholesterol
C0010068||coronary heart disease
C0020456||hyperglycaemia
C0043094||increased bodyweight
C0011860||type 2 diabetes
C0023824||LDL cholesterol
C1426592||PCSK9
C0678941||variants
C0011860||type 2 diabetes
C0005516||biomarkers
C4051515||PCSK9 inhibitors
C2718019||mendelian randomisation study
C0206035||randomised controlled trials
C0007328||case control studies
C1426592||PCSK9
C0678941||genetic variants
C0023824||LDL cholesterol
C1261430||fasting blood glucose
C0019018||HbA1c
C0015663||fasting
C0021641||insulin
C1305855||BMI
C0011860||type 2 diabetes
C0936012||standardised analysis plan
C0920317||meta-analyses
C0237401||individuals
C0011860||type 2 diabetes
C0936012||Combined analyses
C1426592||PCSK9
C0678941||variants
C0678941||rs11583680
C0678941||rs11591147
C0678941||rs2479409
C0678941||rs11206510
C0023824||LDL cholesterol
C0920108||increased fasting glucose
C0011847||diabetes
C0019018||HbA1c
C0015663||fasting
C0021641||insulin
C1305855||BMI
C1426592||PCSK9
C0678941||variants
C0023824||LDL cholesterol
C0920108||higher fasting glucose
C0011860||type 2 diabetes
C0008976||trials
C4051515||PCSK9 inhibitor
C0013227||drugs
C0035173||investigators
C4051515||PCSK9 inhibitor
C0087111||treatment
C0360714||statins
C0016617||British Heart Foundation
C0035172||University College London Hospitals NHS Foundation Trust
C0035172||UCLH
C0035172||National Institute for Health Research (NIHR) Biomedical Research Centre